Flora Peyvandi/X
Aug 23, 2025, 08:25
Flora Peyvandi on Advancements in Complement Inhibition for PNH and Complement-Mediated TMA
Flora Peyvandi, Professor of Internal Medicine-Hemostasis and Thrombosis Unit, University of Milan, former President of ISTH, shared a post on X:
“Advancements in complement inhibition for PNH and primary complement–mediated thrombotic microangiopathy | Blood Advances”
Title: Advancements in complement inhibition for PNH and primary complement–mediated thrombotic microangiopathy
Authors: Thalia Padilla Kelley, Hannah King, Aditya Malhotra, Thomas G. DeLoughery, Kylee Martens, Joseph J. Shatzel
Read the full article here.
Find more recent insights on Hemostasis Today.
-
Aug 10, 2026, 10:30Mansi Kala: Key Takeaways from NHU 2026 in Haemostasis and Laboratory Practice
-
Aug 10, 2026, 08:41Gut Microbiota and Platelet Recovery After Radiation – Platelets Journal
-
Aug 10, 2026, 06:06Mostafa Faisal: What Does High Ferritin Really Mean
-
Aug 10, 2026, 05:45Colin Holburn: Key Laboratory Clues to End Organ Damage
-
Aug 10, 2026, 05:35George Dimitrov: SII and Cancer – What Can This Marker Really Tell Us
-
Aug 10, 2026, 05:01New Clinical Evidence on Emicizumab and Breastfeeding – JTH
-
Aug 10, 2026, 04:53Abdulaziz Elnusiry: Pulmonary Embolism – The Silent Emergency We Need to Talk About
-
Aug 10, 2026, 04:33Saba Javed: Managing VTE in Cancer Patients With Thrombocytopenia
-
Aug 10, 2026, 04:21Heghine Khachatryan: When Cancer Is Not Enough to Predict VTE Risk